Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001242616-12-000013)

Filing Details

Accession Number:: 0001242616-12-000013
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-05-29 14:17:00
Reporting Period:: 2012-05-24

Filing Date:: 2012-05-29
Accepted Time:: 2012-05-29 14:17:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
792977	Amag Pharmaceuticals Inc.	AMAG	Pharmaceutical Preparations (2834)	042742593

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1380022	Michael Narachi	C/O Amag Pharmaceuticals, Inc. 100 Hayden Avenue Lexington MA 02421		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-05-24	2,000	$13.55	2,000	No	4	P	Direct
Common Stock	Acquisiton	2012-05-25	5,500	$0.00	7,500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The shares purchased on this date were purchased in multiple transactions. The actual purchase prices range from $13.9100-$14.0724. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each price.